VIVEbiotech Contributes to the Discussion on the Future of Advanced Therapies
Natalia Elizalde shares her perspective on emerging approaches that could shape the next generation of cell and gene therapies
This is the question explored in the latest Roving Reporter episode by The Medicine Maker and IBTV, recorded at the Advanced Therapies Congress 2026, organized by Terrapinn in London.
The video brings together leading experts from across the cell and gene therapy field to explore the emerging modalities and technologies that could shape the next era of cell and gene therapy.
At 05:57, Natalia Elizalde, PhD, Chief Business Development Officer at VIVEbiotech, shares her perspective:
“From my point of view, the type of products that will have the greatest impact are the in vivo ones, and more specifically, in vivo CAR-Ts”.
At VIVEbiotech, we are proud to support innovation across both ex vivo and in vivo approaches, helping advance the next generation of cell and gene therapies.
👉 Watch the full video here: